Non-Hemostatic Roles of von Willebrand Factor in Gastrointestinal Angiodysplasia: Mechanisms and Therapeutic Implications
Alan (mail bueno) Nurden shared a post on LinkedIn:
“This is an up-to-date and well-written review highlighting the non-hemostatic role of von Willebrand factor in angiodysplasia of the gastro-intestinal tract; a rare condition that complicates life for patients with von Willebrand disease. The role of VWF multimers in binding angiopoietin-2 and growth factors such as vascular endothelial growth factor and presenting them to endothelial cells via avβ3 is emphasized. The authors discuss the signaling pathways that cause increased angiogenesis in vascular deformation syndromes and how these represent possible novel therapeutic targets. The authors are to be congratulated for an informative and highly readable review. It will be interesting to see how this relates to gastrointestinal bleeding in patients with Glanzmann thrombasthenia where angiodysplasia linked to gastrointestinal bleeding is also seen, often for elderly patients, greatly interfering with their quality of life.”
Read the full paper here.
Title: von Willebrand disease and angiodysplasia: a wider view of pathogenesis in pursuit of therapy
Authors: Christina Crossette-Thambiah, Anna M. Randi, Michael Laffan

Find similar posts on Hemostasis Today.
-
Oct 10, 2026, 10:32Randall Schaefer: When Your Prehospital Agency Reports Blood Product Wastage Rates, What is it Really Reporting?
-
Oct 10, 2026, 10:26Simone Strasser: ROTEM-Guided Transfusion Cuts Blood Product Use in Patients with Cirrhosis
-
Oct 10, 2026, 10:18Jérôme S.: WHO Launches Global Roadmap to Combat Hypertensive Disorders of Pregnancy
-
Oct 10, 2026, 10:07Maha Othman: Look Forward to an Amazing ISTH 2027 in Vancouver!
-
Oct 10, 2026, 10:02Rucha Patil: National Convening Highlights Opportunities for Equitable Hemophilia Care Across India
-
Oct 10, 2026, 09:52Yuria Ito: Should Ferritin Testing Become a Routine Part of Prenatal Care in Japan?
-
Oct 10, 2026, 09:48Ahmed Alotaibi: Can We “Remove” the ABO Problem from Group O Platelets?
-
Oct 10, 2026, 09:31Help Shape the New ASH Iron Deficiency Guidelines – American Society of Hematology
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health